PIK3CA and breast cancer: IGF-1R activation signaling through PI3K/Akt/mTOR represents a promising target in BC as an abnormal activation of PI3K can also lead to an increased activation of STAT3 through enhanced expression of the chemokine (C-X-C motif) receptor 4 (CXCR4)[236,237].